PCA3 and posterior cortical atrophy: Our results showed a statisticallysignificant overexpression of 279-fold increase in PSA levelsand a 1,012-fold increase in PCA3 levels in PCa patientscompared to benign prostate disease patients (p = 0.001 andp = 0.002, respectively).